SEC Filing Update: #DNTH Dianthus Therapeutics, Inc. : $107.87

Sector: Healthcare | YTD: 🔼+ 171.99% The SEC disclosed Today (07-AUG-2026) that T. Rowe Price Investment Management, Inc. has INCREASED #DNTH Shares by 200.92% 🟢 * Previous Holdings: 1.29M Shares * Current Holdings: 3.89M Shares * Increase+2.60M * Increased(%)+200.92% * Ownership: 7.1% * Estimated Investment Value: $278.74M https://www.thinksabio.com/reports/isr/DNTH Institutional ownership in #DNTH has been steadily rising over the past 12 quarters in Shares: Q4 2023: 10.29M Q1 2024: 26.08M Q2 2024: 29.70M Q3 2024: 31.36M Q4 2024: 35.13M Q1 2025: 37.72M Q2 2025: 39.11M Q3 2025: 46.84M Q4 2025: 49.12M Q1 2026: 62.13M The quarterly average prices of #DNTH: Q3 2025: $25.54 Q4 2025: $38.72 Q1 2026: $57.91 📌 Institutional activity in the last 30 days for #DNTH: • BLACKROCK INC – Increased holdings by 870,162 shares (28-JUL-2026)